Protagenic Therapeutics, Inc. (PTIXW) is a preclinical biopharmaceutical company based in New York, focused on pioneering innovative therapies for stress-related mood and neuropsychiatric disorders. With a strong commitment to addressing unmet medical needs in mental health, Protagenic leverages its expertise in neurobiology to develop potential treatment solutions that could significantly impact patient outcomes. The company's research initiatives aim to explore novel pathways and therapeutic targets, positioning it as a key player in the burgeoning field of neuropsychiatric health.